Treatment of prostate cancer with CD46 targeted 225Ac alpha particle radioimmunotherapy. Bidkar AP, Wang S, Bobba KN, Chan E, et al. Clin Cancer Res 2023 Mar 14:CCR-22-3291. doi: 10.1158/1078-0432.CCR-22-3291.

Read + Share

Amedeo Smart

Independent Medical Education

Bidkar AP, Wang S, Bobba KN, Chan E, et al. Treatment of prostate cancer with CD46 targeted 225Ac alpha particle radioimmunotherapy. Clin Cancer Res 2023 Mar 14:CCR-22-3291. doi: 10.1158/1078-0432.CCR-22-3291.
PMID: 36917693